Fish & Richardson Trademark & Copyright Thoughts

DECEMBER 20, 2021

Final Determinations were issued by the Commission in two Section 337 Investigations: Certain Electronic Devices, Including Streaming Players, Televisions, Set Top Boxes, Remote Controllers, and Components Thereof , Inv. 337-TA-1200 (Nov. 337-TA-1237 (Nov. 337-TA-1286 (Nov. 337-TA-1262 (Nov. 30, 2021 ).

Television 52

Television Settlement Patent Licensing 52

Fish & Richardson Trademark & Copyright Thoughts

FEBRUARY 5, 2021

We have covered several introductory topics about 337 Investigations at the International Trade Commission (ITC) through the lens of its most common context [1] —as another forum for patent litigation. [2] laws do not govern extraterritorial behavior does not apply to Section 337. [11]. link] (last visited May 8, 2020).

Litigation 52

Litigation Cease and Desist Patent Infringement Intellectual Property 52

Patently-O

MAY 23, 2022

s distinctive approaches to dealing with border control (the ITC’s Section 337 authority) and pharmaceutical patents (Hatch Waxman and the BPCIA). SELECTED TOPICS. It was time to integrate PTAB case management into U.S. patent case management. The project illuminated the U.S.’s THREATS ACTIONS. CRIMINAL PROCEEDINGS.

Patent 67

Patent Litigation Intellectual Property Intellectual Property Law 67

Trading Secrets

DECEMBER 29, 2022

US Law provides two key statutes with civil remedies for protecting trade secrets where the misappropriation occurs extraterritorially—ITC Section 337 (19 U.S.C. Code Section 15.50(a). 1337) and the Defend Trade Secrets Act, 18 U.S.C. 1837—each with different remedies, requirements of applicability, and pros/cons.

Confidentiality 59

Confidentiality Business Law Contracts 59

LexBlog IP

DECEMBER 29, 2022

US Law provides two key statutes with civil remedies for protecting trade secrets where the misappropriation occurs extraterritorially—ITC Section 337 (19 U.S.C. § Code Section 15.50(a). § 1337) and the Defend Trade Secrets Act, 18 U.S.C. §

Confidentiality 40

Confidentiality Business Law Contracts 40

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 11, 2022

The letter discusses the BPCIA and the Hatch-Waxman Act frameworks (for small molecule drugs) and sets forth several topics for USPTO’s consideration and further discussion: engagement between FDA and USPTO to increase efficiencies, possible misuse of the patent system (e.g., 337-TA-3585.). The fate of these bills remains uncertain.

Litigation 52

Litigation Settlement Patent Marketing 52